Tight blood sugar control for pediatric cardiac surgery patients does not improve outcomes

September 10, 2012

Tight blood sugar control in the intensive care unit for pediatric cardiac surgery patients does not improve patients' infection rate, mortality, length of stay or organ failure when compared to standard care, new research shows.

The research, conducted at the University of Michigan's C.S. Mott Children's Hospital and Boston Children's Hospital, will be published Online First in the Sept. 7.

"Post-operative complications for infants and young children who have cardiac surgery remains common, so we want to identify risk factors that we can modify and interventions to help speed their recovery," says Michael G. Gaies, M.D., M.P.H., a physician in the Unit at C.S. Mott, and senior author of the study.

"Tight glycemic control using insulin was shown, in some studies, to improve outcomes in adult cardiac surgery patients, but we didn't know whether children would experience similar benefits."

The researchers studied 980 children from newborn to three years old who were undergoing surgery with cardiopulmonary bypass, representing the largest clinical trial ever performed in pediatric cardiac surgical patients. Patients either received standard cardiac intensive care or tight glycemic control using insulin to target blood glucose at a normal level.

"We found no benefits of tight glycemic control, but the reasons are unclear," says Gaies.

Gaies says that routine control of in pediatric cardiac intensive care units has been controversial because of the contradictory results in adult patients and also concerns about the effects of insulin-induced hypoglycemia on the developing brain.

"This study seems to indicate that tight glycemic control should not be standard practice in units for children who have had cardiac surgery," says Gaies. "We will continue investigating new approaches to improve both short-term recovery and longer-term outcomes for children who need cardiac surgery."

Explore further: Study finds aggressive glycemic control in diabetic CABG patients does not improve survival

More information: doi: 10.1056/NEJMoa1206044

Related Stories

Recommended for you

Researchers find sleep gene linked to heart failure

November 30, 2015

Researchers at the Stanford University School of Medicine have identified a gene that, when working properly, appears to reduce the risk of heart failure and improve treatment outcomes, highlighting a possible target for ...

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.